About Zafrens
Zafrens is a company based in San Diego (United States) founded in 2021 by Yi Zhang. Zafrens has raised $29.16 million across 3 funding rounds from investors including imec.xpand, Prime Movers Lab and Kofa Healthcare. The company has 19 employees as of December 31, 2022. Zafrens offers products and services including Z-Screen, Active-seq, and Active-Drug-seq. Zafrens operates in a competitive market with competitors including 10X Genomics, Mission Bio, Singleron, Cellares and LUMICKS, among others.
- Headquarter San Diego, United States
- Employees 19 as on 31 Dec, 2022
- Founders Yi Zhang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.16 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
imec.xpand
& 9 more
-
Employee Count
19
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zafrens
Zafrens offers a comprehensive portfolio of products and services, including Z-Screen, Active-seq, and Active-Drug-seq.
High-throughput platform for cellular assays and sequencing.
Tool for mapping cell states to functional outcomes.
Platform for simultaneous molecular and phenotypic HTS.
People of Zafrens
Unlock access to complete
Funding Insights of Zafrens
Zafrens has successfully raised a total of $29.16M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zafrens
Zafrens has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include imec.xpand, Prime Movers Lab and Kofa Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in early-stage semiconductor and nanotechnology firms.
|
Locked | Locked | Locked | |
|
Kofa Healthcare is engaged in funding healthcare and biotech innovations.
|
Locked | Locked | Locked | |
|
Global Brain is recognized as a venture capital firm supporting startups.
|
Locked | Locked | Locked |
Investor details for Zafrens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zafrens
Investment portfolio details for Zafrens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zafrens
Detailed financials for Zafrens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zafrens Comparisons
Peer comparison for Zafrens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zafrens
Zafrens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Singleron, Cellares and LUMICKS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| Locked | Locked | Locked |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| Locked | Locked | Locked |
Single-cell imaging platform developed via magnetic levitation technology.
|
Detailed competitors of Zafrens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zafrens
Complete news archive for Zafrens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zafrens
Zafrens was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Zafrens is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Kandaswamy Vijayan is the current CEO of Zafrens.
Zafrens is a funded company, having raised a total of $29.16M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Zafrens is 19.
Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer.
Zafrens's top competitors include 10X Genomics, Mission Bio and Cellares.
Zafrens offers Z-Screen, Active-seq, and Active-Drug-seq.
Zafrens has 10 investors. Key investors include imec.xpand, Prime Movers Lab, Kofa Healthcare, Global Brain, and BlueYard Capital.